Dabomb Protein (6578) — Capital Reinvestment Ratio
Dabomb Protein (6578) has a Capital Reinvestment Ratio of 2.53x as of March 2025, meaning it reinvests 3% of its operating cash flow (NT$8.12 Million) in capital expenditures (NT$20.59 Million). Check Dabomb Protein tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Dabomb Protein Capital Reinvestment Ratio (2015–2025)
This chart tracks Dabomb Protein's Capital Reinvestment Ratio across 10 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Dabomb Protein.
Annual Capital Reinvestment Ratio for Dabomb Protein (2015–2025)
Year-by-year Capital Reinvestment Ratio for Dabomb Protein from 2015 to 2025. See Dabomb Protein (6578) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 2.26x | NT$16.65 Million | NT$37.69 Million | ▲ +255.1% |
| 2024 | 0.64x | NT$47.55 Million | NT$30.32 Million | ▼ -78.0% |
| 2023 | 2.90x | NT$6.51 Million | NT$18.87 Million | ▲ +183.6% |
| 2022 | 1.02x | NT$19.71 Million | NT$20.16 Million | ▼ -25.1% |
| 2020 | 1.37x | NT$13.41 Million | NT$18.31 Million | ▼ -50.5% |
| 2019 | 2.76x | NT$33.26 Million | NT$91.81 Million | ▼ -62.6% |
| 2018 | 7.39x | NT$22.07 Million | NT$163.06 Million | ▲ +94.7% |
| 2017 | 3.79x | NT$43.87 Million | NT$166.46 Million | ▲ +143.9% |
| 2016 | 1.56x | NT$59.58 Million | NT$92.71 Million | ▲ +3977.6% |
| 2015 | 0.04x | NT$139.78 Million | NT$5.33 Million | — |